Reaction Details Report a problem with these data
Target
Bromodomain-containing protein 4 [368-440]
Ligand
BDBM249292
Substrate
n/a
Meas. Tech.
Homogeneous Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay
pH
7.5±n/a
Temperature
298.15±n/a K
IC50
131.0±n/a nM
Comments
extracted
Citation
 Aktoudianakis, E; Chin, G; Corkey, BK; Du, J; Elbel, K; Jiang, RH; Kobayashi, T; Lee, R; Martinez, R; Metobo, SE; Mish, M; Munoz, M; Shevick, S; Sperandio, D; Yang, H; Zablocki, J Benzimidazole derivatives as bromodomain inhibitors US Patent  US9458145 Publication Date 10/4/2016 
Target
Name:
Bromodomain-containing protein 4 [368-440]
Synonyms:
BRD4 | BRD4_HUMAN | Bromo domain 2 | Bromodomain-containing protein 4 (BD2) | Bromodomain-containing protein 4 (BRD4) Bromo 2 | Bromodomain-containing protein 4 (BRD4)(BD2) | Bromodomain-containing protein 4 (BRD4)(Bromo 2) | Bromodomain-containing protein 4 Bromo 2 domain(BRD4 BD2) | Bromodomain-containing protein 4 Bromodomain 2 (BRD4-2) | Bromodomain-containing protein 4 Domain 2 | HUNK1
Type:
Protein
Mol. Mass.:
8564.63
Organism:
Homo sapiens (Human)
Description:
BD2 (368-440 aa) of O60885
Residue:
73
Sequence:
KHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVV
  
Inhibitor
Name:
BDBM249292
Synonyms:
US10017501, Compound 1020-88 | US9458145, 1020-88
Type:
Small organic molecule
Emp. Form.:
C26H22N6O
Mol. Mass.:
434.4925
SMILES:
Cc1noc(C)c1-c1cc(-c2c(C)ccc3ncccc23)c2nc([nH]c2c1)-c1cnn(C)c1 |(2.9,3.95,;1.56,4.72,;1.09,6.18,;-.45,6.18,;-.93,4.72,;-2.26,3.95,;.32,3.81,;.32,2.27,;1.65,1.5,;1.65,-.04,;2.99,-.81,;4.32,-.04,;4.32,1.5,;5.65,-.81,;5.65,-2.35,;4.32,-3.12,;4.32,-4.66,;2.99,-5.43,;1.65,-4.66,;1.65,-3.12,;2.99,-2.35,;.32,-.81,;-0,-2.32,;-1.53,-2.48,;-2.16,-1.07,;-1.02,-.04,;-1.02,1.5,;-2.3,-3.81,;-1.83,-5.28,;-3.07,-6.18,;-4.32,-5.28,;-5.65,-6.05,;-3.84,-3.81,)|
Structure:
Search PDB for entries with ligand similarity: